Jan 21, 2020

Scientists discover why some cancers may not respond to immunotherapy -- ScienceDaily

Scientists have discovered that people with cancers containing genetic mutations JAK1 or JAK2, which are known to prevent tumors from recognizing or receiving signals from T cells to stop growing, will have little or no benefit from the immunotherapy drug pembrolizumab. This early-stage research has allowed them to determine for the first time why some people with advanced melanoma or advanced...

Proceed to the page: http://linkis.com/sfswf

Similar Articles Added Earlier

Similar Articles Added Today

Most Recent sciencedaily.com Articles

Latest Links Processed

0/120